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Abstract
Background: Evidence mapping describes the quantity, design and characteristics of research in broad topic areas,
in contrast to systematic reviews, which usually address narrowly-focused research questions. The breadth of
evidence mapping helps to identify evidence gaps, and may guide future research efforts. The Global Evidence
Mapping (GEM) Initiative was established in 2007 to create evidence maps providing an overview of existing
research in Traumatic Brain Injury (TBI) and Spinal Cord Injury (SCI).
Methods: The GEM evidence mapping method involved three core tasks:
1. Setting the boundaries and context of the map: Definitions for the fields of TBI and SCI were clarified, the
prehospital, acute inhospital and rehabilitation phases of care were delineated and relevant stakeholders (patients,
carers, clinicians, researchers and policymakers) who could contribute to the mapping were identified. Researchable
clinical questions were developed through consultation with key stakeholders and a broad literature search.
2. Searching for and selection of relevant studies: Evidence search and selection involved development of specific
search strategies, development of inclusion and exclusion criteria, searching of relevant databases and independent
screening and selection by two researchers.
3. Reporting on yield and study characteristics: Data extraction was performed at two levels - ‘interventions and study
design’ and ‘detailed study characteristics’. The evidence map and commentary reflected the depth of data extraction.
Results: One hundred and twenty-nine researchable clinical questions in TBI and SCI were identified. These
questions were then prioritised into high (n = 60) and low (n = 69) importance by the stakeholders involved in
question development. Since 2007, 58 263 abstracts have been screened, 3 731 full text articles have been reviewed
and 1 644 relevant neurotrauma publications have been mapped, covering fifty-three high priority questions.
Conclusions: GEM Initiative evidence maps have a broad range of potential end-users including funding agencies,
researchers and clinicians. Evidence mapping is at least as resource-intensive as systematic reviewing. The GEM
Initiative has made advancements in evidence mapping, most notably in the area of question development and
prioritisation. Evidence mapping complements other review methods for describing existing research, informing
future research efforts, and addressing evidence gaps.
Background
All stakeholders in health care like to have research evi-
dence to inform their decision-making. Some decisions
relate to questions that are narrowly focused, such as
the effectiveness of an intervention or the accuracy of a
diagnostic test. Others are much broader, such as the
relative effectiveness of various treatment options
available for a particular condition. The methods of sys-
tematic reviews are well developed for the former group,
but the latter poses many challenges for locating, orga-
nising, collating and synthesising information into a use-
ful, understandable format, as it requires an organised
up-to-date reference source of research evidence addres-
sing broad content areas.
For this task, existing evidence resources seem gener-
ally inadequate. Finding all relevant publications on a
topic using PubMed-type databases is a long and labor-
ious task. Systematic reviews are rarely completely up-
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ven collaboration, the Cochrane Library doesn’t necessa-
rily contain reviews encompassing all questions in a
given topic area. Furthermore neither searches for pri-
mary studies, nor systematic reviews are well suited to
identifying important evidence gaps.
Techniques for describing existing evidence in a broad
content area are relatively new, and have been called
evidence mapping and scoping studies [1,2]. How they
compare with systematic reviews is shown in Table 1.
Importantly, evidence mapping and scoping does not
extend to the quality appraisal and synthesis techniques
associated with systematic reviews. Scoping is further
distinguished from mapping by the inclusion of research
results in the description of relevant evidence. Three
publications have outlined methods for mapping or
scoping a content area [3-5], which have included three
core tasks:
1. Setting the boundaries and context of the topic
area in question;
2. Searching for and selection of relevant studies;
and
3. Reporting on yield and study characteristics.
In 2007 the Global Evidence Mapping (GEM) Initia-
tive was established with funding from the Victorian
Neurotrauma Initiative (VNI), a research funding agency
established by the Victorian Government’s Transport
Accident Commission and Department of Innovation
Industry and Regional Development [6]. The GEM
Initiative developed as a collaboration of clinical,
research and policy stakeholders to provide an overview
of existing research about Traumatic Brain Injury (TBI)
and Spinal Cord Injury (SCI).
The GEM Initiative aimed to map the available
research for the prehospital, acute inhospital and rehabi-
litation phases of care for TBI and SCI. The breadth of
clinical research questions and volume of studies in
these areas is considerable. The evidence mapping
approach was thought to be the most appropriate
method because its main purpose is to provide an over-
view of a broad range of research questions and identify
evidence gaps [3-5]. In creating the SCI and TBI evi-
dence maps, the GEM Initiative drew on and advanced
evidence mapping methods. Importantly, we developed
an in-depth question development process, which
enabled us to satisfy a key project aim - the identifica-
tion of evidence gaps - by comparing and contrasting
stakeholder-driven clinical research questions with pub-
lished literature.
This article focuses on the GEM Initiative’se v i d e n c e
mapping methods and illustrates how these methods
were applied to neurotrauma (TBI and SCI) topics. The
results of the mapping process itself are also briefly
described.
Methods
Figure 1 summarises the steps of the GEM Initiative evi-
dence mapping process (centre of figure), their relation-
ship to previously published core evidence mapping
tasks (left of figure) and the resulting outputs (right of
figure). The figure also illustrates the boundary between
evidence mapping and the other secondary research
methods described in Table 1.
Because evidence mapping outputs have stand-alone
merit and application, the GEM evidence mapping pro-
cess, like previously published evidence mapping meth-
ods, is not an ‘all or nothing’ proposition; the number of
steps undertaken and the breadth of the topic area cov-
ered can therefore vary according to available resources.
An evidence map can form the basis of a scoping review
or number of individual systematic reviews, as evidence
mapping produces source materials for both these activ-
ities (Table 1). Further, analysis of the evidence gaps
identified in the mapping process can aid planning of
Table 1 Methods of identifying and collating research evidence
Method Definition Purpose Breadth Depth of process
Systematic
Review
“an overview of primary studies which
contains an explicit statement of
objectives, materials and methods and has
been conducted according to explicit and
reproducible methodology.” [22]
Summarise overall quality and
results of a body of research;
inform clinical practice
Addresses a
focused
clinical
question
[13]
In depth searching, quality appraisal and
synthesis of studies relevant to the
identified clinical question
Scoping
Study
Overview of “the key concepts
underpinning a research area and the
main sources and types of evidence
available” Mays et al. 2001; cited in [3]
Examine the extent, range and
nature of research activity; identify
research gaps [3]
Covers a
broad topic
area
Identifying boundaries and context of
the area under study, followed by
searching, collation and summary of
study characteristics and results with no
quality appraisal or synthesis
Evidence
Mapping
The systematic organisation and
illustration of a broad field of research
evidence [3,5]
Characterise the breadth, depth,
methodology of relevant evidence
and make this readily accessible
[5]; identify research gaps
Covers a
broad topic
area
Identifying boundaries and context of
the area under study and providing a
description of yield, interventions, study
design and study characteristics
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effort within topic areas, and focussing research efforts
on high priority topics (Figure 1).
Following is an in-depth description of the GEM
Initiative evidence mapping methods, illustrated with
specific examples from our evidence maps. Emphasis
has been placed upon the unique aspects of these meth-
ods; the use of a mapping workshop to identify clinical
research questions, development of questions, question
prioritisation and the two levels of data extraction and
presentation.
Core task 1: Setting the boundaries and context of the
map
The GEM Initiative approached this task using two dis-
tinct steps - question development and question
prioritisation.
STEP 1: Question Development
The question development phase involved four broad
data collection exercises designed to gain an overview of
the scope of the field and gather perceptions of key sta-
keholders - patients, carers, clinicians, researchers and
policymakers - regarding the key clinical issues in the
field of interest. The data gathered from these exercises
was used to develop searchable clinical questions.
1A: Expert Consultation Consultation with experts has
been identified as a useful strategy for setting the
boundaries and context of an evidence map [4,5].
Experts identify specific terminology, which aids in
search strategy development, and outline who has stake-
holder interests. This information informs subsequent
stages of the mapping process [4,5].
To frame the TBI and SCI evidence maps, the GEM
Initiative consulted with local and international clinical
and research leaders in these fields. These consultations
involved introducing the GEM Initiative and the concept
of evidence mapping, followed by an unstructured discus-
sion designed to enhance our understanding of specific
aspects of TBI and SCI care. For example, our discussion
with experts in SCI rehabilitation encompassed common
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Figure 1 GEM Initiative Evidence Mapping Methods.
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care and the healthcare disciplines involved in managing
these.
Although the GEM Initiative focused on clinicians and
researchers, the other key stakeholders with expert
knowledge in this area - patients, carers and policy-
makers (who were involved in later stages in the GEM
process) - can add different perspectives to this process
and could also be involved at this stage.
1B: Preliminary literature search To identify existing
relevant reviews and guidelines relating to TBI and SCI
in each of the phases of care, a preliminary literature
search was conducted by a GEM Initiative project officer
who had extensive Cochrane systematic review experi-
ence. Major medical databases were searched using rele-
vant Medical Index Subject Headings (MeSH) and other
terms based upon the clinical knowledge of the GEM
researchers. The focus of the search was on reviews and
guidelines rather than primary studies. Relevant reviews
and guidelines were used to identify clinical questions,
describe the extent to which they had been addressed by
existing literature and identify additional key literature
search terms. This information further developed the
scope of the map.
1C: Mapping Workshop T oe n s u r et h ee v i d e n c em a p s
were comprehensive and useful, key stakeholders
involved in all phases of TBI and SCI patient care -
patients, carers, clinicians, researchers and policymakers
- were invited to participate in mapping workshops.
This is an enhancement on the techniques for obtaining
expert opinion described by Katz et al. [5].
The primary aim of the mapping workshops was to
gather stakeholder perspectives on key clinical questions,
outcomes, patient factors and contextual factors affect-
ing TBI and SCI care. A total of four mapping work-
shops were conducted; one each for the pre-hospital
and rehabilitation phase of care in which both SCI and
TBI stakeholders were involved; and separate TBI and
SCI workshops dealing with the acute inhospital phase
of care.
The nominal group technique [7] was used. This
involved individual, anonymous generation of ideas fol-
lowed by group discussion. The nominal group techni-
que overcomes the inhibiting influences that can
operate when group interaction is used to generate ideas
[7]; examples of such inhibiting influences include a
health professional deferring to a senior colleague rather
than offering their own opinion, or a patient not want-
ing to highlight issues that could be construed as criti-
cism of their clinicians.
A professional facilitator with experience in the nom-
inal group technique ran the workshops. The mapping
workshops varied in length from one to two hours
according to the breadth of the field and participant
availability. A consistent workshop format was employed
comprising:
￿ Introduction: Aims, key definitions, confidentiality/
consent procedures.
￿ Brainstorming: Writing of ideas on individual
adhesive notes, without discussion. The PICO format
(’Problem’, ‘Intervention’, ‘Comparator’, ‘Outcome’)
was suggested but not mandatory. Clinical issues
could include diagnosis, prognosis, interventions,
and service delivery/organisation. The adhesive notes
were then placed on large sheets around the room.
￿ Prioritisation: During a short refreshment break,
GEM Initiative researchers grouped similar notes.
Participants then prioritised the notes by placing a
limited number of adhesive dots next to the notes
they perceived as most important.
￿ Discussion: Open discussion was conducted on the
ideas generated, the results of the prioritisation and
any further issues identified. This was a valuable way
of gaining insight into other perspectives and elabor-
ating, modifying and developing consensus [7].
Where time permitted, the issue of contextual fac-
tors (for example rural or urban location, socioeco-
nomic status) and their influence on the feasibility of
delivering an intervention, the intervention itself,
outcomes, or other aspects of care was discussed.
￿ Conclusion: Participants were thanked and invited
to participate in subsequent question development
and prioritisation activities and/or receive a copy of
the final report.
The mapping workshops resulted in an unstructured
collection of ideas and PICO terms of interest as well as
a sense of the relative importance of these ideas.
1D: Online survey An online survey was used to aug-
ment the information gathered in the mapping work-
shops. Only one published evidence mapping method has
incorporated the use of a survey. The GEM Initiative evi-
dence mapping survey built on the method described by
Katz et al. [5] by placing an emphasis on the PICO ele-
ments that form the basis of searchable clinical questions
and, like the mapping workshop, bringing patients into
the process of generating ideas and questions.
Survey recipients were identified through GEM clinical
and research contacts, primary searching of hospital and
academic websites and organisational mailing lists,
including a mailing list of clinicians and researchers on
the VNI database to which GEM staff were blinded. The
survey comprised three sections:
1. Introduction and background: Brief background to
the project, purpose, confidentiality and contact
information.
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asked to fill in a minimum of two blank PICO tem-
plates identifying a series of clinical problems, thera-
pies and/or outcomes that they considered
important in their specialty area.
3. Demographic details: Profession/patient group,
years experience or years a patient, extent of
research/clinical involvement in TBI/SCI, geographi-
cal location, gender.
T h es u r v e yd a t aw e r em o r ec l o s e l ya l i g n e dt ot h e
PICO format than the mapping workshop data, as the
survey responses were mandated under PICO headings.
1E: Development of questions These four activities (1A
-1D) generated a very large volume of unstructured
ideas including single words, PICO fragments, state-
ments and questions. They varied in format, language,
perspective and emphasis because a range of stake-
holders was involved in the process.
Organisation of this heterogeneous data was required
in order to promulgate a key aim of the GEM Initiative
- the identification of evidence gaps - by searching for
literature pertaining to the identified issues. We
addressed this need by transforming the data into a list
of ‘answerable’ clinical research questions. An ‘answer-
able’ question seeks specific knowledge, is framed to
facilitate literature searching and therefore, follows a
semi-standardised structure [8,9]. The challenge of
representing broad stakeholder perspectives in answer-
able question form has been recognised by Bates et al.
[4]. The GEM Initiative used an in-depth, systematic
process for transforming the data from steps 1A - 1D
into answerable clinical research questions that
involved:
1. Entering data into an electronic database (Micro-
soft Excel).
2. Coding the clinical problems described using
codes from the International Classification of Func-
tioning, Disability and Health (ICF) [10,11]. This
comprehensive framework was suitable for identify-
ing the broad range of clinical issues across multiple
phases of TBI and SCI care; for other evidence map-
ping topic areas, other taxonomies may be more
appropriate for coding purposes.
3. Collating coding information to identify the
range and frequency of all codes represented in the
data.
4. Conducting a series of half-day question construc-
tion meetings in which the GEM Initiative research
team transformed the data into a list of answerable
clinical research questions encompassing all ICF
codes represented in the data.
The example in Table 2 illustrates the transformation
of data from steps 1A - 1D into an answerable clinical
research question using this approach.
A range of question development strategies have been
reported in published evidence mapping projects. Arksey
[12] used qualitative analysis to identify the key topics
and issues arising from stakeholder consultation in her
scoping review of interventions for carers of people with
mental health problems. Bates et al. [4] used a PICO-
style approach to frame inclusion and exclusion criteria
for literature search and other mapping tasks. Similarly,
Arksey et al. [3] discussed the importance of defining key
question parameters and recommended framing such
parameters to maximise breadth of literature coverage.
The GEM Initiative approach to question development
built upon these strategies by using the ICF framework
to organise large amounts of unstructured data and
detailing the specific tasks involved in transforming this
data into answerable clinical research questions. This
approach facilitated the development of a large number
(129) of answerable research questions across an entire
research field. The comprehensive question development
approach used by the GEM Initiative ensured that all of
the ideas identified by the key stakeholders in steps 1A -
1D - patients, carers, clinicians, researchers and policy-
makers - were represented in the final list of answerable
clinical research questions for each phase.
STEP 2: Question Prioritisation
Bates et al. [4] recognised that the evidence mapping
process involves calibratin gt h ea n s w e r a b l eq u e s t i o n s
developed against the resources available to map these
questions. Given the number of questions identified in
the GEM Initiative question development process, there
was a clear need to prioritise these as our project
resources did not enable all steps of the mapping pro-
cess to be applied to all identified questions.
The GEM Initiative involved the key stakeholders
from the question development process in prioritising
the list of clinical research questions from Step 1. An
online survey of patients, clinicians and researchers was
conducted. Survey recipients included participants from
the mapping workshop, the GEM advisory group and
other representatives with expert knowledge of TBI and
SCI. Survey respondents were asked to rank each
searchable clinical question on three domains - clinical
importance (’How clinically important is this question?’),
novelty (’Does this question represent an emerging area
of clinical practice?’) and controversy (’What is the level
of variability regarding opinion and/or practice for this
question?’) - using a scale of 1 to 4, where:
1 = not at all
2 = a little
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4 = high.
The questions were then ranked into two broad cate-
gories:
￿ High priority questions: Questions where the
majority of respondents ranked ‘Clinical Importance’
as high AND (’Novelty’ OR ’Controversy’ as high or
moderate).
￿ Low priority questions: All other questions.
This ranking procedure was arbitrary and driven by
the imperatives of the GEM Initiative project; other
research groups may use other ranking parameters and
divisions consistent with the focus of their research
activity. For example, cost-effectiveness or feasibility of
undertaking primary or secondary research, rather than
clinical importance, may be deemed the most important
determinants of which questions to pursue.
Core task 2: Searching for and selection of relevant
studies
STEP 3: Evidence Search and Selection
The evidence search and selection methods used by the
GEM Initiative were consistent with accepted principles
of systematic reviewing. Specifically, these were:
1. In-depth search strategies using applicable MeSH
headings and keywords [9,13].
2. Pre-determined inclusion criteria [4,13].
3. Searching a broad range of medical databases.
4. Review of retrieved citations/full-text articles
against the question-specific inclusion criteria by
two independent reviewers to reduce bias [3,13].
As such methods are extensively documented in sys-
tematic review methodology literature, only a brief
description of their specific application to the GEM
Initiative follows. Examples are contained in Appendix 1.
3A: Development of search strategy An information
specialist was used to develop and run searches and col-
late search results. Search strategies were built by com-
bining at least two of:
￿ Core terms representing TBI and SCI
￿ Filter terms, for example to target rehabilitation
literature
￿ Intervention terms specific to the clinical questions
being mapped.
GEM Initiative researchers with a clinical background
(the research team included two medical doctors, a phy-
siotherapist and a nurse) contributed their clinical
knowledge of the subject areas to search strategy devel-
opment. Abridged versions of the search strategy were
used for the databases that had a simpler search inter-
face or smaller content, such as non-English databases,
as these databases could not accommodate a large num-
ber of search terms [4,14].
3B: Development of inclusion criteria A priori eligibil-
ity criteria were developed regarding study type (sys-
tematic reviews and a broad range of primary study
designs encompassing therapy, diagnosis and prognosis
were included; animal, laboratory, cadaver and simula-
tion studies were excluded), participants (explicit defini-
tions of TBI and SCI) and phase of care (prehospital,
acute inhospital, rehabilitation; injury prevention
research was excluded).
Given the breadth of topics covered, question-specific
refinements to the inclusion criteria were sometimes
Table 2 Transformation of question development data into an answerable clinical research question
Data source Example of data ICF code
[10,11]
Resulting answerable clinical research
question
1A: Expert
consultation
“Spasticity” b735: Muscle
tone
functions
1B: Preliminary
literature
search
“What are the best pharmacological treatments to manage TBI
spasticity?”
“How effective is intrathecal baclofen, botulinum toxin type A, passive
exercises etc?”
b735: Muscle
tone
functions
What are effective interventions for
preventing and managing skeletal muscle
spasticity?
1C: Mapping
workshop
“Problem: spasticity management”
“Decreased joint range of motion and integrity”
“Spasticity causing functioning or safety problem”
b735: Muscle
tone
functions
1D: Online
survey
“P: Spasticity
I: Pharmacological management of tonal changes, surgical
intervention, positioning techniques, gentle movement program,
patient/family education
O: Maximise passive and/or active joint range and maintain optimal
joint integrity”
b735: Muscle
tone
functions
ICF: International Classification of Functioning, Disability and Health.
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review; for example, to determine which clinical sub-
categories of a particular disorder were most relevant.
Such post hoc refinements, which can only occur when
some literature has been examined [3], also aided in the
classification of eligible studies. For example, the man-
agement of spasticity in TBI could be divided into surgi-
cal, pharmacological and physical therapies. Where
necessary, changes to the search strategy were made to
reflect these alterations and refinements. A similar itera-
tive approach has been adopted by others [4].
3C: Literature searching Major medical databases
(including non-English) and trials registries were
searched for all phases of care covered by the GEM
Initiative. Searching of further databases tailored to the
specific needs of each phase/question was also con-
ducted. For example, for the question pertaining to
spasticity, three additional databases were searched to
reflect the multidisciplinary nature of this intervention
in addition to the databases routinely searched (Appen-
dix 1).
For all searches there was no restriction on year of
publication or language. For each question all of the
chosen databases were searched on the same day and a
reference library (Endnote) of search results by database
was compiled. The reference library was then de-dupli-
cated for the purpose of screening and selection.
3D: Preliminary screening: titles/abstracts Retrieved
citations were reviewed against the question-specific
inclusion criteria by two independent reviewers. Where
necessary, a third reviewer was used to resolve disagree-
ments by breaking a tie.
3E: Full-text article procurement Full-text articles
identified during screening were procured either directly
or via order from university/hospital libraries.
3F: Final screening: full-text articles Full-text articles
were reviewed against inclusion criteria as described
above (3D).
Records of screening and selection decisions (citations
excluded; citations identified for full text review; cita-
tions agreed upon for full text review; studies excluded
upon full-text review; studies identified for inclusion in
evidence map; studies agreed upon for inclusion in evi-
dence map) were systematically kept.
As a search of all the major and auxiliary databases
may inadequately reflect the total relevant research on
any topic [15,16], reference lists of relevant articles were
systematically searched by GEM reviewers [13] and
expert clinicians were consulted to identify further
potentially relevant articles.
Core task 3: Reporting on yield and study characteristics
The GEM Initiative undertook two levels of evidence
mapping reporting; an overview of interventions (where
relevant) and study design of included studies and a
more in-depth exploration of study characteristics. In
each case, the output tables and text identified and
articulated evidence gaps by describing how the relevant
literature addressed the research question. These levels
of evidence mapping are described and illustrated below
with examples from the GEM Initiative evidence maps.
STEP 4: Data Extraction
A relational data extraction database was created
(Microsoft Access), which could be interrogated to
explore and query the evidence map [4].
For the prehospital evidence map, an in-depth data
extraction and review of study quality was undertaken.
However this process proved to be unfeasible once the
volume and breadth of literature in subsequent phases
became apparent. Furthermore, it was felt that quality
appraisal, summary of findings and specific outcomes of
individual studies was better conducted within a formal
systematic review, and we have distinguished evidence
maps and systematic reviews in part on this level of data
extraction and reporting as outlined earlier. This
resulted in the development of the two data extraction
protocols that were used in the rehabilitation and
acute inhospital evidence maps:
4A: Interventions and study design Extracting to this
level involved identifying the number of studies by study
design for each intervention addressing the question.
Where the question did not pertain to an intervention,
relevant studies were listed by study design only. For all
phases of the project, study design was classified accord-
ing to the definitions outlined in the Australian National
Health and Medical Research Council (NHMRC) levels
of evidence [17] and Straus et al. [9]. A brief commen-
tary on evidence summarised the key findings regarding
the yield and breakdown of study interventions and
designs (Table 3).
4B: Detailed study characteristics The following data
were extracted: study design, country, sample size,
source population, interventions, outcome measures,
patient factors (demographics, injury classification). This
facilitated a more in-depth evidence map for the clinical
question, as reflected by both the output table and the
scope of the commentary on evidence (Table 4).
Use of these two data extraction methods facilitated a
broad coverage of clinical questions in these areas
within project resources. The decision regarding which
data extraction method to use involved consideration of
a range of factors including the nature and complexity
of the question and the need to balance consistency,
comprehensiveness and question coverage across both
TBI and SCI topics.
Complete versions of tables and reports exemplifying
both styles of data extraction are available at http://
www.evidencemap.org. This site contains a searchable
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map has been completed. For each topic, either the out-
put tables (’maps’) alone (as illustrated in Tables 3 and
4) can be downloaded, or a report is available containing
the maps plus a background to the topic, the inclusion
criteria for search, the search strategy and yield, a
description of the map, a commentary on evidence and
a reference list. The date of last update is also listed for
each topic.
Results
Although this paper focuses on the steps of the evidence
mapping process, a brief overview of the findings of the
GEM mapping process itself illustrates its usefulness in
identifying evidence gaps.
Question development
Since the inception of the GEM Initiative, a total of 129
answerable clinical research questions have been gener-
ated, covering the prehospital (n = 30; 17 TBI, 13 SCI),
acute inhospital (n = 37; 18 TBI, 19 SCI) and rehabilita-
tion (n = 62; 26 TBI, 36 SCI) phases of TBI and SCI
care.
Question Prioritisation
The prioritisation procedure undertaken in the GEM
Initiative resulted in 60 of the 129 clinical research
questions being identified as high priority; 30 in each of
TBI and SCI.
Evidence Search and Selection
Since 2007, 58 263 abstracts have been screened, 3 731
full text articles have been reviewed and 1 644 relevant
neurotrauma publications have been identified.
Data Extraction
Data extraction has been completed to produce evidence
maps for fifty-three high priority questions. For 11 of
the 53 questions (3 TBI, 8 SCI), gaps in primary
research evidence were identified:
￿ For six questions (2 TBI, 4 SCI) no studies were
identified.
￿ For a further four questions pertaining to interven-
t i o n s( 1T B I ,3S C I ) ,o n l yc a s es e r i e s ,c a s es t u d yo r
cross-sectional study designs were identified. These
represent neurotrauma research topics in which
Table 3 Example of ‘interventions and study design’ output: Prevention and management of skeletal muscle spasticity
in the rehabilitation phase of TBI
Intervention n SR RCT X-over Cohort ITS Case series Case report
Casting/splinting 16 1 2 1 2 5 5
TENS 2 1 1
Baclofen: Intrathecal long term 16 1 3 11 1
Baclofen: Intrathecal bolus/test dose 5 1 3 1
Baclofen: Oral 1 1
Botulinum toxin (Botox) 10 3 1 2 4
Clonidine 1 1
Lower leg casting/splinting & Botox 1 1
Cryotherapy 1 1
Phenol nerve block 1 1
Weight-bearing gait retraining 1 1
Divolproex sodium 1 1
Bobath treatment 1 1
Voice and respiration treatment 1 1
Rhythmic, passive movement 1 1
Seating 1 1
Combination of therapies 1 1
SR: Systematic Review.
RCT: Randomised Controlled Trial.
X-over: Crossover trial.
ITS: Interrupted Time Series.
TENS: Transcutaneous Electrical Nerve Stimulation.
Commentary on evidence.
Over half of the 61 studies investigated pharmacological/neurotoxin therapies for managing spasticity in TBI. However, no systematic review of this literature was
identified. The next most common intervention under investigation was casting/splinting. One systematic review of this intervention was identified [23]. Only ten
of the 61 studies investigated therapies other than pharmacological/neurotoxin agents or casting/splinting.
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trolled Trial, Pseudo-Randomised Controlled Trial,
Case-Control Study) are needed, as reflected by the
NHMRC levels of evidence for intervention studies
[17].
￿ For a further question pertaining to prognosis in
SCI, no prospective cohort studies were identified,
which are the highest ranked primary study for
investigating prognosis [17].
TBI topics with primary evidence gaps included pre-
hospital therapeutic hypothermia and participation in
leisure and social activities. SCI topics with primary evi-
dence gaps included prehospital antiemetic medications
and interventions for sleep disordered breathing.
A further 12 questions (9 TBI, 3 SCI) contained sec-
ondary evidence gaps; more than one comparative study
were identified, but no systematic review. These are
neurotrauma research topics in which research synthesis
may be warranted. TBI topics with secondary evidence
gaps included prehospital hyperventilation and interven-
tions for minimising drug and alcohol misuse. SCI
topics with secondary evidence gaps included interven-
tions for atelectasis/chest infections and interventions
for optimising nutrition and body weight.
Discussion
The GEM Initiative has produced evidence maps that
may be useful to research funders, researchers, clinicians
and other research consumers. An extensive list of
prioritised research questions in a topic area, even in
the absence of study retrieval and data extraction, is a
potential springboard for research, research funding and
policy development. Because the question development
and prioritisation process is driven by consultation with
key stakeholders - patients, carers, clinicians, researchers
and policymakers - this list is more likely to be relevant
to real-world issues than research questions driven
solely by academic researchers. Our experience of the
power of engaging with a wide stakeholder group is
shared by Arksey et al. [3], who reflected on the addi-
tional insights that this approach gives to the process.
Developing and prioritising research questions by con-
sulting with a number of stakeholder groups carries the
dual advantage of adding breadth to the research topics
identified and diluting the potential influence of indivi-
dual or stakeholder group biases on the question devel-
opment process.
Funding agencies can use evidence maps to access
completed/ongoing studies in a topic area; for example,
studies using intrathecal baclofen for spasticity in TBI.
This information can aid in evaluating the need for
further funded research when reviewing a grant applica-
tion. The collection of evidence maps across a whole
topic area (for example, TBI rehabilitation) also high-
lights areas of high and low research activity, potentially
informing strategic research funding decisions. The VNI
exemplified this application of evidence maps through
its explicit instructions to funding applicants to consult
the GEM evidence maps in the process of preparing
their applications [18]. Other research-informed agen-
cies could also benefit from evidence maps - for exam-
ple, a policy-maker could gain an understanding of the
volume and nature of research in a topic area to aid in
funding or other policy decisions.
Researchers can use evidence maps to inform research
decisions and designs. Evidence maps parallel all steps
of a traditional systematic review except in-depth quality
appraisal and synthesis. Systematic reviewers can there-
fore use evidence maps as a resource for updating an
existing systematic review, or to evaluate the feasibility
and resource requirements of a systematic review based
Table 4 Example of ‘detailed study characteristics’ output (extract only): Effective interventions for optimising bowel
function in the rehabilitation phase of SCI
Reference Study
Design
Country n Pop. Patient
Group
Condition Intervention Outcomes
Ayas et al.
2006 [24]
Case series Turkey 24 All
SCI
Adult Neurogenic
bowel
Abdominal
massage
Mean time for bowel evacuation; Frequency of
defecation; Faecal incontinence; Abdominal
distension; Abdominal pain; Difficult intestinal
evacuation
Furusawa
et al. 2007
[25]
Case series Japan 15 All
SCI
Adult Autonomic
Dysreflexia
Bowel program
involving manual
removal of stool
BP; Pulse; Symptoms of cervical SCI
Luther et
al. 2005
[26]
Retrospective
cohort
USA 370 All
SCI
Adult Neurogenic
bowel
Bowel care
program;
Colostomy
Training for bowel care program; Quality of life;
Subjective complication rates
Commentary on evidence.
Two systematic reviews were identified in this topic area covering colostomy and ileostomy and multimodal bowel management and over half (21) of the
eligible primary studies were case series. Five studies recruited over 100 patients. Four of these were exclusively SCI populations, however, the largest study in
the evidence map that was on multimodal bowel management (n = 837), comprised a mixed population with no subgroup analysis. The majority of studies
assessed specific physiological parameters, such as time to flatus and number of bowel evacuations. Only seven studies assessed quality of life measures.
(Note: this commentary refers to studies not contained in the above table, which is an extract of a table containing the 34 included studies).
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sal and synthesis using this resource. One example of
such a review is a Cochrane review of interventions for
managing skeletal muscle spasticity, which built upon
the GEM evidence map of this topic [19]. As illustrated
i nt h er e s u l t s ,a ne v i d e n c em a po fas p e c i f i ct o p i cc a n
also avoid duplication of primary research and deter-
mine where further primary studies are needed or con-
versely, identify if a systematic review of existing studies
may be more appropriate. Studies included in an evi-
dence map could also aid primary research planning, for
example by describing outcome measures or research
protocols.
Clinicians can use evidence maps to rapidly access
research information pertaining to specific populations
and interventions. For example, a case manager could
access literature about the effectiveness of community
integration programs for TBI specifically in paediatric
populations, or focusing on computer-based interven-
tions. However, it should be emphasised that evidence
mapping does not purport to guide clinical practice, as
the studies in the GEM Initiative evidence maps have
not been subject to quality appraisal or had their results
synthesised.
This limitation of evidence mapping necessitates cau-
tion especially in cases where a large volume of evidence
is identified for a topic. For example, for eleven of the
GEM topics (4 TBI, 7 SCI) over 50 relevant English arti-
cles were identified. These represent neurotrauma
research topics in which knowledge translation research,
rather than more primary or secondary studies, may be
appropriate. However, this cannot be surmised from the
yield alone, but by combining this with an examination
of the quality of the comparative studies and/or sys-
tematic reviews. Should the research be of high quality
and consistency, knowledge translation research may be
warranted. If this is not the case, further primary or sec-
ondary studies are required - just as in cases where
there is a low volume of evidence. Avoiding the poten-
tial hazard of misreading evidence maps is best facili-
tated by transparency in the description of the purpose
and methods of evidence mapping, in particular by
drawing a clear distinction between evidence mapping
and systematic reviewing (Figure 1); ensuring that the
results of the evidence maps themselves are not pre-
sented as definitive statements on the direction of
research evidence; and promoting research that fills the
evidence gaps identified by the mapping process.
Identification of and prolonged engagement with the
likely end-users (clinicians, researchers, funding agen-
cies) starting early in an evidence mapping project
enables tailoring of evidence mapping activities and out-
puts to their priorities. Although there was provision in
the evidence mapping process for the identification and
mapping of non-intervention questions, the existing
GEM evidence resource predominantly contains maps
pertaining to interventions. This could be in part due to
the use of PICO to guide question development; it may
be a reflection of the priorities of those involved in
question development; or it could be a simple illustra-
tion that most clinical research questions are interven-
tion-focused. In this context, some tailoring to the
evidence mapping process could be necessitated (for
example, less emphasis on PICO) if outputs focused on
non-intervention issues are identified as important dur-
ing initial consultation with end-users.
There are many resource-intensive steps in evidence
mapping. As described, the GEM Initiative evidence
maps involved the generation of 129 clinical questions
and independent review of tens of thousands of
abstracts and thousands of full-text articles by the 3.5
EFT project staff. A similar level of staffing has been
reported by Arksey et al. [3]. Preliminary calculations
performed by the GEM Initiative, based on time spent
to develop detailed search strategies, search databases
and select studies, indicate a resource cost of 1.5 min-
utes for each citation reviewed [20], plus the costs of
setting the boundaries and context of the map and
reporting on yield and study characteristics.
Our experiences in this project combined with the
available cost data reinforce the statement by Arksey et
al. [3] that “the scoping study should not be seen as a
cheap alternative to the systematic review” (p. 29). Pri-
marily this is because any savings in resource use from
not synthesising and appraising studies to the depth of a
systematic review are easily overtaken by the costs asso-
ciated with mapping a much broader topic area. Given
the resource requirements of evidence mapping, efficien-
cies (that do not compromise scientific rigor) must be
explored in order to ensure the long-term sustainability
of evidence mapping.
Conclusions
Since its inception in August 2007, the GEM Initiative
has advanced the field of evidence mapping. The in-
depth question development and prioritisation methods
- in particular the use of mapping workshops to engage
a broad range of key stakeholders - result in evidence
maps that are more likely to be relevant to patients,
carers, clinicians, researchers and policymakers. This
question development method could easily adapt to any
situation requiring the generation of clinical questions.
The study search and selection methods parallel
accepted systematic review approaches, creating poten-
tial synergies with systematic reviewing. The possibility
of fruitful collaborations between evidence mappers and
systematic reviewers has been identified by other evi-
dence mapping authors [4,5]. Given the resource-
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strategic advantages and efficiencies of such collabora-
tions are clear.
Two levels of data extraction have been explored by
the GEM Initiative; an overview of interventions and
study design, and a more in-depth description of study
characteristics. These highlight the many potential out-
puts and applications of evidence maps and the ability
of the evidence mapping process to be tailored to spe-
cific needs. In highlighting the usefulness of evidence
maps in scoping research in broad topic areas, it is
acknowledged that this breadth of coverage comes at
the cost of evidence synthesis and quality appraisal,
and therefore evidence maps cannot be used to guide
clinical practice. This limitation should be borne in
mind when reporting on and disseminating evidence
maps.
Evidence maps complement other forms of reviews for
use by researchers, clinicians, patients, carers and policy-
makers with an interest in accessing and using evidence
resources.
Appendix 1 - Examples of search and selection
procedures used by the GEM Initiative
Step 3A: Search Strategy: Intervention Search string for
‘spasticity’ used in Medline (April 2008)
1. Muscle Spasticity/
2. spastic*.mp.
3. 1 or 2
4. Botulinum Toxin Type A/
5. exp GABA Agonists/
6. exp gamma-Aminobutyric Acid/
7. “gamma amino butyric acid*”.mp.
8. or/4-7
9. “Range of Motion, Articular"/
10. stretch*.mp.
11. Splints/
12. position*.mp.
13. exp Physical Therapy Modalities/
14. physiotherap*.mp.
15. Occupational Therapy/
16. or/9-15
17. Rhizotomy/or rhizotomy.mp.
18. myelotomy.mp.
19. Cordotomy/or cordotomy.mp.
20. cordectomy.mp.
21. or/17-20
22. or/8,16,21
23. 3 and 22
Step 3B: Inclusion criterion: ‘Rehabilitation’ phase of care
Subacute care and long term care through community
management. Subacute care is defined as medical and
skilled nursing services provided to patients who are not
in an acute phase of an illness but who require a level
of care higher than that provided in a long term care
setting. Long term care includes community manage-
ment and is defined as extended care for chronic condi-
tions or disabilities requiring periodic, intermittent, or
continuous care [21].
Step 3C: Databases searched for TBI rehabilitation
question: What are effective interventions for preventing
and managing skeletal muscle spasticity?
Major medical databases:
Cumulative Index to Nursing and Allied Health Lit-
erature (CINAHL), OVID Embase, OVID Medline, Psy-
cINFO, Cochrane Library, ISI Web of Science, PubMed
Non-English databases:
India Med, Korea Med, LILACS, Panteleimon
Trials registries:
WHO - International Clinical Trials Registry Platform
(ICTRP), The UK National Research Register
Further databases (to reflect the multidisciplinary nat-
ure of this intervention):
Physiotherapy Evidence Database (PEDro), OTSeeker,
PsycBITE
Steps 3D - 3F: Search and selection results for TBI
rehabilitation question: What are effective interventions
for preventing and managing skeletal muscle spasticity?
673 titles/abstracts screened
152 full-text articles ordered and reviewed
61 articles included in evidence map (one ongoing
trial and three non-English studies were also identified)
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